Precipio Launches COVID-19 Antibody Testing at Point-of-Care

Following the receipt of FDA EUA by Nirmidas, Precipio begins market roll out to POC
NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc.
(NASDAQ:… [read more]

Leave a Comment